4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics

Understanding neurophysiology is essential for neuroanaesthesia and neurocritical care. The brain represents only 2% of total body weight (~1400 g in an adult) yet consumes 20% of resting oxygen and 25% of systemic glucose. Because brain tissue lacks meaningful intracellular nutrient storage, neuronal viability depends on an uninterrupted, highly regulated cerebral microcirculation.

---

1. Quantitative Foundations of Cerebral Perfusion and Metabolism

Normal resting global cerebral blood flow (CBF) averages 50 mL/100g/min (approximate range: 45–55 mL/100g/min). In an adult with an average brain mass of 1400 g, total CBF is approximately 750 mL/min, representing 15% of resting cardiac output.

Perfusion is markedly heterogeneous throughout the brain:

• Cortical grey matter: Receives approximately 80 mL/100g/min, reflecting high neuronal cell body density and intense synaptic activity.
• Subcortical white matter: Receives approximately 20 mL/100g/min, reflecting the lower metabolic maintenance requirements of myelinated axonal tracts.

Cerebral Metabolic Rate for Oxygen ($CMRO_2$)

The brain consumes oxygen at a resting rate of 3.0 to 3.5 mL/100g/min (~45–50 mL/min total, or 20% of whole-body basal $VO_2$). Cellular energy consumption is divided into two primary components:

1. Functional (signaling) metabolism (~60% of $CMRO_2$): Generates and restores ionic gradients across neuronal membranes following action potentials and synaptic transmission (primarily mediated by $\text{Na}^+/\text{K}^+$-ATPase pump activity).
2. Basal (cellular integrity) metabolism (~40% of $CMRO_2$): Maintains basic cellular architecture, organelle function, membrane synthesis, and intracellular transport.

Flow-Metabolism Coupling

Under physiological conditions, regional CBF is tightly coupled to local metabolic demand (metabolic autoregulation). Activated cortical regions release vasoactive mediators into the perivascular extracellular fluid, inducing local arteriolar vasodilation. Key mediators include:

• Hydrogen ions ($H^+$) and lactate from local glycolysis
• Extracellular potassium ions ($K^+$) released during repetitive neuronal depolarization
• Adenosine released from ATP hydrolysis
• Nitric oxide (NO) synthesized by neuronal and endothelial nitric oxide synthase (nNOS/eNOS)
• Prostanoids and epoxyeicosatrienoic acids (EETs) released via astrocyte end-feet contacting cerebral microvessels

---

2. Autoregulation of Cerebral Blood Flow

Cerebral autoregulation describes the intrinsic capacity of the cerebral vascular bed to maintain a constant blood flow despite fluctuations in perfusion pressure.

$\text{CBF} = \frac{\text{CPP}}{\text{CVR}}$

Where $\text{CPP}$ is cerebral perfusion pressure and $\text{CVR}$ is cerebrovascular resistance.

The Autoregulation Plateau

In normotensive adults, CBF remains constant across a mean arterial pressure (MAP) range of 50 to 150 mmHg (or a CPP range of roughly 50 to 150 mmHg):

• Myogenic mechanism (Bayliss effect): Increased transmural vascular wall tension stretches arteriolar smooth muscle, triggering membrane depolarization, calcium influx via L-type voltage-gated channels, and arteriolar constriction, which elevates CVR.
• Lower limit of autoregulation (MAP ~50 mmHg): Arterioles reach maximal vasodilation. Below 50 mmHg, CBF becomes passively pressure-dependent. Perfusion falls linearly, causing hypoperfusion, tissue hypoxia, cellular energy failure, and ischemia.
• Upper limit of autoregulation (MAP ~150 mmHg): Arteriolar smooth muscle cannot resist intraluminal hydrostatic pressure. Vasoconstriction fails, resulting in "forced vasodilation" (autoregulatory breakthrough). High pressure transmits directly into fragile capillaries, causing blood-brain barrier disruption, vasogenic cerebral edema, microhemorrhages, and hypertensive encephalopathy.

   CBF (mL/100g/min)
      ^
  100 |                     Breakthrough Hyperperfusion
      |                               /---------
   50 |         /====================/
      |        /   (Autoregulatory Plateau)
      |       /     MAP 50 - 150 mmHg
      |      /
      |     / Ischemic
    0 +----+-----+-----+-----+-----+-----+-----> MAP (mmHg)
      0   25    50    75   100   125   150   175

Pathophysiological Shifts in Autoregulation

• Chronic arterial hypertension: Structural vascular remodeling (smooth muscle hypertrophy and arteriolar hyalinosis) shifts the entire autoregulation curve to the right (e.g., limits shift to 80–180 mmHg MAP). While this protects the microvasculature from acute pressure spikes, the lower limit of autoregulation is elevated. Acute reductions of blood pressure into the "normal" range (e.g., MAP 65 mmHg) can precipitate severe cerebral ischemia.
• Acute brain pathology: Severe traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), ischemic stroke, and central nervous system infections frequently abolish autoregulation entirely ("pressure-passive" circulation). In this state, any reduction in MAP directly lowers CBF, while any increase in MAP elevates ICP.

---

3. Chemical, Physical, and Pharmacological Determinants of CBF

Arterial Carbon Dioxide Tension ($P_a\text{CO}_2$)

Carbon dioxide is the most potent physiological chemical regulator of cerebral vasomotor tone. Between 20 and 80 mmHg (2.7 to 10.7 kPa), the relationship between $P_a\text{CO}_2$ and CBF is nearly linear:

• For every 1 mmHg change in $P_a\text{CO}_2$, CBF changes by 1 to 2 mL/100g/min (approx. 2–4% change in flow).
• Mechanism: Molecular $CO_2$ is highly lipophilic and diffuses rapidly across the blood-brain barrier. In the perivascular extracellular fluid, $CO_2 + H_2O \rightleftharpoons H_2CO_3 \rightleftharpoons H^+ + \text{HCO}_3^-$. Elevated $[H^+]$ relaxes vascular smooth muscle via potassium channel activation ($K_{\text{ATP}}$ and $K_{\text{Ca}}$). Conversely, systemic arterial $[H^+]$ cannot cross the intact BBB and has no direct immediate effect on CBF.
• Temporal limitation: Hyperventilation lowers $P_a\text{CO}_2$ and rapidly constricts cerebral vessels, lowering ICP within minutes. However, active transport of bicarbonate out of the CSF and choroid plexus buffering restores perivascular pH to normal within 24 to 48 hours. Therefore, therapeutic hyperventilation is a temporary bridge, and abrupt cessation causes rebound vasodilation and ICP spikes.

Temperature and the $Q_{10}$ Effect

Cerebral metabolism follows the temperature coefficient ($Q_{10}$), which for the human brain is approximately 2.0 to 2.5. $CMRO_2$ decreases by approximately 7% for every 1°C decrease in brain temperature:

• Deep hypothermia (18–20°C): Induces electroencephalographic (EEG) silence. Because functional electrical metabolism (~60%) is extinguished and basal cellular metabolism is halved, brain tolerance to complete circulatory arrest increases from 5 minutes at 37°C to over 30–45 minutes at 18°C.
• Hyperthermia: Fever markedly increases $CMRO_2$ and CBF, aggravates secondary ischemic injury, and promotes intracranial hypertension. Maintaining strict normothermia (36.0–37.0°C) is mandatory in neurocritical care.

Anaesthetic Pharmacology on CBF and $CMRO_2$

• Volatile Inhalational Anaesthetics (isoflurane, sevoflurane, desflurane): Possess dose-dependent dual actions. They suppress neuronal metabolic activity (reducing $CMRO_2$), but exert direct smooth muscle relaxant effects on cerebral arterioles. Below 1.0 MAC, metabolic suppression balances vasodilation; above 1.0 MAC, direct vasodilation dominates, causing increased CBF, cerebral blood volume, and ICP.
• Nitrous Oxide ($N_2O$): Produces cerebral vasodilation and increases both $CMRO_2$ and CBF, particularly when combined with volatile agents.
• Intravenous Induction Agents (propofol, thiopental, etomidate): Maintain intact flow-metabolism coupling. They cause parallel, dose-dependent reductions in both $CMRO_2$ and CBF (up to a ceiling of 50–55% suppression when burst suppression is achieved on EEG), reducing cerebral blood volume and ICP.
• Ketamine: Unique exception among IV agents. As a non-competitive NMDA receptor antagonist, ketamine stimulates limbic structures, increases $CMRO_2$, and causes profound cerebral vasodilation, increasing CBF by up to 60%. Although its ICP-elevating effects can be partially blunted by controlled normocapnic ventilation and co-administration of GABAergic agents, ketamine is traditionally avoided in acute neurotrauma with compromised intracranial compliance.

---

4. Intracranial Pressure Dynamics and the Monro-Kellie Doctrine

The Monro-Kellie Hypothesis

The cranium is a rigid, non-distensible vault with a fixed internal volume. In a healthy adult, this space is occupied by three distinct physiological compartments:

$V_{\text{intracranial}} = V_{\text{brain}} + V_{\text{CSF}} + V_{\text{blood}} = \text{Constant}$

• Brain parenchyma: ~80% (~1400 mL; intracellular and extracellular fluid, glia, neurons)
• Cerebrospinal fluid (CSF): ~10% (~150 mL)
• Intracranial blood: ~10% (~150 mL; ~70–80% resides in low-pressure venous sinuses and capillarovenous beds, ~20–30% in arterial vessels)

Because total intracranial volume is constant, an abnormal volume addition (e.g., hematoma, tumor, cerebral edema) must be offset by an equal reduction in one or both of the physiological fluid compartments. This is the spatial compensation phase:

1. Translocation of CSF out of the cranial vault into the compliant lumbosacral spinal subarachnoid space.
2. Acceleration of CSF absorption through arachnoid villi into the superior sagittal sinus.
3. Compression and displacement of low-pressure cerebral veins and dural venous blood into the systemic circulation.

   ICP (mmHg)
      ^
   60 |                                         / (Decompensated)
      |                                        /   High Elastance
   40 |                                       /
      |                                      /
   20 |                          ___________/
      |                         /  (Knee of Curve: Spatial Exhaustion)
    0 +------------------------+------------------------------------> Intracranial Volume
      0             Compensated Phase (High Compliance)

Intracranial Compliance and Elastance

• Compliance ($C = \frac{\Delta V}{\Delta P}$): The change in volume per unit change in pressure. During early mass expansion, compliance is high, so ICP remains within normal limits (5 to 15 mmHg).
• Elastance ($E = \frac{\Delta P}{\Delta V}$): The inverse of compliance. Once spatial compensatory mechanisms are exhausted ("the knee of the curve"), compliance plummets and elastance rises steeply. At this point, minute volume additions (e.g., 2–5 mL from cough-induced venous engorgement or hypercapnic vasodilation) provoke massive spikes in ICP.
• Pathological threshold: Sustained intracranial pressure > 20 to 22 mmHg requires aggressive intervention to prevent secondary ischemia and cerebral herniation.

Cerebral Perfusion Pressure (CPP)

Cerebral perfusion pressure drives blood across the cerebral vascular bed:

$CPP = MAP - ICP \quad (\text{or } CVP, \text{ whichever is higher})$

Under normal conditions, ICP (5–15 mmHg) exceeds central venous pressure (CVP). However, if CVP is pathologically elevated (e.g., tension pneumothorax, excessive PEEP, tricuspid regurgitation), CVP replaces ICP as the effective backpressure (Starling resistor mechanism).

• Clinical targets: In traumatic brain injury and neurocritical care, the internationally recommended target CPP is 60 to 70 mmHg.
• Risks of extremes: A CPP < 60 mmHg risks secondary ischemic insult. Conversely, aggressively driving CPP > 70–80 mmHg with high-dose vasopressors increases hydrostatic capillary filtration, aggravating vasogenic brain edema and increasing the incidence of acute respiratory distress syndrome (ARDS).

Brain Herniation Syndromes

When compartmental pressure gradients develop across rigid intracranial dural folds, brain tissue shifts:

1. Uncal (transtentorial) herniation: Medial temporal lobe (uncus) herniates downward through the tentorial notch. Compresses the ipsilateral oculomotor nerve (CN III) causing an ipsilateral fixed, dilated pupil, and compresses the midbrain cerebral peduncle causing contralateral hemiparesis (Kernohan notch phenomenon can cause paradoxical ipsilateral hemiparesis).
2. Subfalcine (cingulate) herniation: Cingulate gyrus shifts under the falx cerebri, compressing the anterior cerebral artery (ACA) and causing contralateral lower extremity weakness.
3. Central tentorial herniation: Downward displacement of bilateral cerebral hemispheres and basal ganglia compressing the diencephalon and brainstem, causing decorticate posturing progressing to decerebrate rigidity.
4. Cerebellar tonsillar herniation ("coning"): Cerebellar tonsils are forced downward through the foramen magnum, compressing the medulla oblongata, leading to respiratory arrest, sudden Cushing triad (hypertension, bradycardia, irregular respiration), and death.

---

5. Cerebrospinal Fluid (CSF) Physiology and Blood-Brain Barrier (BBB)

CSF Formation and Circulation

• Volume and Production: Total adult CSF volume is approximately 150 mL (~25–30 mL in the cerebral ventricles, remainder in the subarachnoid space). CSF is produced at 0.35 mL/min (~500 mL/day), meaning the total CSF pool turns over 3 to 4 times per day.
• Sites of production: Approximately 70–80% is secreted actively by the choroid plexuses situated within the lateral, third, and fourth ventricles; the remaining 20–30% originates as interstitial fluid filtration across ependymal surfaces.
• Cellular mechanism: Polarized choroid epithelial cells use basolateral $\text{Na}^+/\text{K}^+$-ATPase and carbonic anhydrase to transport sodium and bicarbonate into the ventricles, with water following down the resulting osmotic gradient through aquaporin-1 channels. Production is an active metabolic process that remains constant over normal physiological ranges of ICP, declining only when CPP approaches zero.
• Circulation pathway: $\text{Lateral Ventricles} \xrightarrow{\text{Foramina of Monro}} \text{Third Ventricle} \xrightarrow{\text{Aqueduct of Sylvius}} \text{Fourth Ventricle}$ $\xrightarrow{\text{Foramina of Luschka (lateral) \& Magendie (midline)}} \text{Cisterna Magna \& Subarachnoid Space} \xrightarrow{} \text{Arachnoid Granulations}$
• Reabsorption: CSF is reabsorbed into the superior sagittal and dural venous sinuses via arachnoid villi and granulations. Reabsorption is a passive, bulk-flow process governed by the hydrostatic pressure gradient between CSF and dural sinus blood (normal gradient ~5–7 $\text{cmH}_2\text{O}$). Arachnoid villi act as one-way micro-valves; when ICP exceeds dural venous pressure, valves open. If dural pressure exceeds ICP, the villi collapse, preventing venous reflux.

Blood-Brain Barrier (BBB) Structure

The BBB isolates the cerebral microenvironment from systemic circulating neurotoxins, neurotransmitters, and electrolyte fluctuations:

• Continuous, non-fenestrated capillary endothelial cells: Sealed by complex, high-electrical-resistance intercellular tight junctions (claudins, occludins, junctional adhesion molecules, and zonula occludens ZO-1).
• Basement membrane: Continuous basal lamina enclosing pericytes.
• Astrocyte end-feet: Ensheath 99% of the capillary surface, inducing and maintaining tight junction integrity.
• Permeability characteristics: Lipophilic molecules (volatile anaesthetics, opioids, benzodiazepines, $O_2, CO_2$) diffuse freely across the lipid membranes. Water-soluble, charged, or polar compounds (ions, mannitol, proteins) cannot pass passively and require specialized carrier proteins or receptor-mediated transport. The reflection coefficient ($\sigma$) for sodium, chloride, and mannitol across an intact BBB is close to 1.0 (impermeable).

Osmotherapy: Mannitol vs Hypertonic Saline

When the BBB is intact, administering hypertonic solutions expands intravascular osmolality, establishing a trans-endothelial osmotic pressure gradient that draws free water from the intracellular and interstitial compartments of normal brain tissue into the cerebral circulation, shrinking brain volume and lowering ICP within minutes.